Association between Icotinib Efficacy and Circulating Tumor Cell Levels in Advanced Non-Small Cell Lung Cancer

被引：0
|
作者：
Huang, Y. [1 ]
Wang, W. [2 ]
Xu, C. [3 ]
Zhuang, W. [1 ]
Song, Z. [2 ]
Huang, Z. [1 ]
Lin, G. [1 ]
Chen, X. [4 ]
Wu, B. [1 ]
Chen, Y. [3 ]
Chen, G. [3 ]
Fang, M. [2 ]
机构：
[1] Fujian Prov Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Prov Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[4] Fujian Prov Canc Hosp, Thorac Surg, Fuzhou, Fujian, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
icotinib; non-small cell lung cancer; Circulating tumor cells;
D O I：
10.1016/j.jtho.2017.09.1450
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-008
引用
收藏
页码：S2203 / S2203
页数：1
相关论文
共 50 条
  • [31] Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine
    Juan, O.
    Vidal, J.
    Gisbert, R.
    Munoz, J.
    Macia, S.
    Gomez-Codina, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (07) : 637 - 643
  • [32] EFFICACY AND SAFETY OF ANLOTINIB COMBINED WITH ICOTINIB IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG CANCER
    Chen, Hualin
    Luo, Yiping
    Lin, Muwen
    Peng, Xiaoxia
    Liu, Meilian
    Huang, Zhong
    Wang, Yongcun
    Li, Shujun
    Yang, Donghong
    Yang, Zhixiong
    ACTA MEDICA MEDITERRANEA, 2022, 38 (03): : 2035 - 2040
  • [33] Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine
    O. Juan
    J. Vidal
    R. Gisbert
    J. Muñoz
    S. Maciá
    J. Gómez-Codina
    Clinical and Translational Oncology, 2014, 16 : 637 - 643
  • [34] Effects of Docetaxel Combined with Icotinib on Serum Tumor Markers and Quality of Life of Patients with Advanced Non-Small Cell Lung Cancer
    Lin, Huawei
    Chang, Jing
    Li, Jun
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2020, 49 (10) : 1885 - 1893
  • [35] CLINICAL OBSERVATION FROM THE TREATMENT OF ICOTINIB FOR 196 CASES WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Gu, Qin A.
    Han, Hui B.
    Jiang, Yan L.
    Wang, Min H.
    Shi, Lei C.
    Xiong, Wen L.
    Zhao, Zhuo Y.
    Chu, Qing T.
    Pei, Jun
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S598 - S598
  • [36] Application of Circulating Tumor DNA as a Biomarker for Non-Small Cell Lung Cancer
    Yang, Jialiang
    Hui, Yan
    Zhang, Yanxiang
    Zhang, Minghui
    Ji, Binbin
    Tian, Geng
    Guo, Yangqiang
    Tang, Min
    Li, Lianxing
    Guo, Bella
    Ma, Tonghui
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [37] Prognostic Importance of Circulating Tumor Cells in Non-small Cell Lung Cancer: A Prospective Study
    Bi, Hong-Xia
    Shi, Han-Bing
    Sun, Xing-Yuan
    Su, Jiang
    Mao, Zong-Fu
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2015, 14 (09) : 1723 - 1731
  • [38] Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
    Shishido, Stephanie N.
    Carlsson, Anders
    Nieva, Jorge
    Bethel, Kelly
    Hicks, James B.
    Bazhenova, Lyudmila
    Kuhn, Peter
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [39] Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer
    Stephanie N. Shishido
    Anders Carlsson
    Jorge Nieva
    Kelly Bethel
    James B. Hicks
    Lyudmila Bazhenova
    Peter Kuhn
    Journal of Translational Medicine, 17
  • [40] Circulating tumor cells in non-small cell lung carcinoma
    Boshuizen, Rogier
    Kuhn, Peter
    van den Heuvel, Michel
    JOURNAL OF THORACIC DISEASE, 2012, 4 (05) : 456 - 458
12345